SEC Charges Ex-Biopharmaceutical Company Vice President With Insider Trading
March 11, 2025
March 11, 2025
WASHINGTON, March 11 -- The Securities and Exchange Commission issued the following litigation release (No. 3:25-cv-00539; S.D. Cal. filed Mar. 7, 2025) involving George N. Demos:
* * *
On March 7, 2025, the Securities and Exchange Commission filed charges against George Demos, a former Vice President of Drug Safety and Pharmacovigilance at Acadia Pharmaceuticals Inc., for insider trading in advance of Acadia's March 8, 2021 announcement of negative news from the F . . .
* * *
On March 7, 2025, the Securities and Exchange Commission filed charges against George Demos, a former Vice President of Drug Safety and Pharmacovigilance at Acadia Pharmaceuticals Inc., for insider trading in advance of Acadia's March 8, 2021 announcement of negative news from the F . . .